Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-19

FDA Approved: ERYTHROMYCIN LACTOBIONATE — Original Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved the original application for erythromycin lactobionate from Gland Pharma Limited (ANDA216761). This marks the approval of a generic erythromycin la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERYTHROMYCIN LACTOBIONATE (erythromycin lactobionate)

Snippet

ORIG AP for ERYTHROMYCIN LACTOBIONATE (ERYTHROMYCIN LACTOBIONATE)